S. 4333 · 117th Congress

CLEAR Act

Stage
In committee
Sponsor
Tina Smith
Introduced
2022-05-26
Latest action
2022-05-26 · Introduced in Senate

Summary

Consistent Legal Evaluation And Regulation of Medical Products Act or the CLEAR Act

This bill requires the Food and Drug Administration to regulate contrast agents for medical imaging devices, radioactive drugs, over-the-counter monograph drugs, and ophthalmic drug articles (i.e., eye droppers) as drugs rather than medical devices.